Tamar D Wohlfarth

Summary

Affiliation: Medicines Evaluation Board of the Netherlands
Country: The Netherlands

Publications

  1. ncbi request reprint Response to tricyclic antidepressants: independent of gender?
    Tamar Wohlfarth
    Medicines Evaluation Board of the Netherlands, Den Haag, The Netherlands
    Am J Psychiatry 161:370-2. 2004
  2. ncbi request reprint Antidepressants use in children and adolescents and the risk of suicide
    Tamar D Wohlfarth
    Medicenes Evaluation Board of the Netherlands, The Hague
    Eur Neuropsychopharmacol 16:79-83. 2006
  3. doi request reprint Psychopharmacology for children: from off label use to registration
    Tamar Wohlfarth
    Medicines Evaluation Board of the Netherlands, The Netherlands
    Eur Neuropsychopharmacol 19:603-8. 2009

Detail Information

Publications3

  1. ncbi request reprint Response to tricyclic antidepressants: independent of gender?
    Tamar Wohlfarth
    Medicines Evaluation Board of the Netherlands, Den Haag, The Netherlands
    Am J Psychiatry 161:370-2. 2004
    ..The authors examined gender differences in response to tricyclic antidepressants...
  2. ncbi request reprint Antidepressants use in children and adolescents and the risk of suicide
    Tamar D Wohlfarth
    Medicenes Evaluation Board of the Netherlands, The Hague
    Eur Neuropsychopharmacol 16:79-83. 2006
    ..Antidepressants use in paediatric patients has been linked with risk of suicidal behaviours. The aim of this paper, therefore, is to examine whether all antidepressants are associated with such risk...
  3. doi request reprint Psychopharmacology for children: from off label use to registration
    Tamar Wohlfarth
    Medicines Evaluation Board of the Netherlands, The Netherlands
    Eur Neuropsychopharmacol 19:603-8. 2009
    ..Specific methodological issues were discussed, such as the role of different informants and the high rate of comorbidity...